Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

Celcuity Inc.

NotesSupport
aboutterms

Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

Celcuity Inc.

CIK 0001603454CELC· quarter ending 2026-06-30
Shares outstanding
48,931,908
as of 2026-08-05 · 10-Q cover page, filed 2026-08-13
Held by 13F filers
190,819,200
selection includes debt or preferreds — no % of shares outstanding
Holders
19
-5 vs 2026-03-31 · 3 new, 8 exited
Value
$428.8M
shares -0.1% vs prior quarter
13F holdings exceed the share count. This is normal for heavily shorted stocks: shares lent to short sellers are reported by the lender and again by whoever bought them. Related filers occasionally report the same position twice as well.

Share classes (cover page of the 10-Q filed 2026-08-13, as of 2026-08-05)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common stockCELC · NASDAQ48,931,90856,985,890116.5%27315102K100

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
15102K100COM27356,985,89048,931,908116.5%$6.0B7 call / 5 put13DGholders →
15102KAB6NOTE 0.250% 8/0not common422,000,000
$561.1M principal
——$635.4M—NPORTholders →
15102KAA8NOTE 2.750% 8/0not common19
$190.8M principal
——$428.8M—NPORTholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings.

Top holders (19 of 19 · 15102KAA8)

change vs 2026-03-31
#FilerShares / principal% of classValueChange
1Linden Advisors LP112,901,000—$254.5M+20,186,000 (+21.8%)
2BAKER BROS. ADVISORS LP30,750,000—$69.2M—
3Context Capital Management, LLC15,970,000—$36.0M+1,000,000 (+6.7%)
4CAPSTONE INVESTMENT ADVISORS, LLC7,000,000—$15.8M+6,000,000 (+600.0%)
5PERCEPTIVE ADVISORS LLC6,500,000—$14.6M—
6CSS LLC/IL5,310,000—$11.9M-1,000,000 (-15.8%)
7FMR LLC2,256,000—$5.1M-10,000 (-0.4%)
8WOLVERINE ASSET MANAGEMENT LLC2,114,000—$4.8MNEW
9Acasta Partners UK LLP2,000,000—$4.5M-2,000,000 (-50.0%)
10BNP PARIBAS FINANCIAL MARKETS1,668,000—$3.7MNEW
11ADVENT CAPITAL MANAGEMENT /DE/980,000—$2.2M—
12JPMORGAN CHASE & CO922,000—$2.0M+320,000 (+53.2%)
13LAZARD ASSET MANAGEMENT LLC832,000—$19KNEW
14AGF MANAGEMENT LTD600,000—$1.3M—
15GOLDMAN SACHS GROUP INC409,000—$919K—
16MILLENNIUM MANAGEMENT LLC350,000—$789K—
17Kohlberg Kravis Roberts & Co. L.P.153,000—$345K-132,000 (-46.3%)
18Ares Systematic Credit Ltd100,000—$225K—
19SG Americas Securities, LLC4,200—$943K—
Exited since 2026-03-31 (8 filers; largest 8 shown)
Jump Financial, LLC−9,504,000
DeepCurrents Investment Group LLC−6,000,000
LORD, ABBETT & CO. LLC−5,936,000
SSI INVESTMENT MANAGEMENT LLC−3,206,000
Affinity Asset Advisors, LLC−3,000,000
Polar Capital Holdings Plc−750,000
OAKTREE CAPITAL MANAGEMENT LP−600,000
Central Pacific Bank - Trust Division−153,000

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
BANK OF AMERICA CORP /DE/SCHEDULE 13G2026-08-112026-06-303,170,1986.5%
Felix J. BakerSCHEDULE 13G2026-07-162026-07-144,877,9639.99%
Julian C. BakerSCHEDULE 13G2026-07-162026-07-144,877,9639.99%
Baker Bros. Advisors (GP) LLCSCHEDULE 13G2026-07-162026-07-144,877,9639.99%
Baker Bros. Advisors LPSCHEDULE 13G2026-07-162026-07-144,877,9639.99%
Roderick WongSCHEDULE 13G2026-05-152026-03-313,039,6216.3%
RTW Investments, LPSCHEDULE 13G2026-05-152026-03-313,039,6216.3%
Rick YangSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Edward T. MathersSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Ali BehbahaniSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Paul WalkerSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
NEA Partners 18 VGE, L.P.SCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
NEA 18 VGE GP, LLCSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
NEA 18 Venture Growth Equity, L.P.SCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Mohamad H. MakhzoumiSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Scott D. SandellSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Growth Equity Opportunities 18 VGE, LLCSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Anthony A. Florence, Jr.SCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Carmen ChangSCHEDULE 13D/A2026-03-092026-03-052,285,5614.9%
Perceptive Life Sciences Master Fund, Ltd.SCHEDULE 13G/A2026-02-172025-12-313,160,2006.8%
Joseph EdelmanSCHEDULE 13G/A2026-02-172025-12-313,160,2006.8%
Behzad AghazadehSCHEDULE 13G2026-02-172025-12-313,111,1116.72%
Avoro Capital Advisors LLCSCHEDULE 13G2026-02-172025-12-313,111,1116.72%
Perceptive Advisors LLCSCHEDULE 13G/A2026-02-172025-12-313,160,2006.8%
Soleus GP, LLCSCHEDULE 13G/A2026-02-122025-12-311,806,8743.9%
Guy LevySCHEDULE 13G/A2026-02-122025-12-311,808,2583.9%
Soleus PE GP II, LLCSCHEDULE 13G/A2026-02-122025-12-31142,1180.3%
Soleus Capital Master Fund, L.P.SCHEDULE 13G/A2026-02-122025-12-311,664,7563.6%
Soleus Capital Management, L.P.SCHEDULE 13G/A2026-02-122025-12-311,806,8743.9%
Soleus Capital, LLCSCHEDULE 13G/A2026-02-122025-12-311,664,7563.6%
Soleus Capital Group, LLCSCHEDULE 13G/A2026-02-122025-12-311,664,7563.6%
Soleus Private Equity Fund II, L.P.SCHEDULE 13G/A2026-02-122025-12-31142,1180.3%
Soleus Private Equity GP II, LLCSCHEDULE 13G/A2026-02-122025-12-31142,1180.3%
LAMPERT MARK NSCHEDULE 13G/A2025-11-142025-09-30658,4211.6%
BVF II GP LLCSCHEDULE 13G/A2025-11-142025-09-30268,7750.6%
BVF Partners OS Ltd.SCHEDULE 13G/A2025-11-142025-09-3036,2700.09%
Biotechnology Value Trading Fund OS LPSCHEDULE 13G/A2025-11-142025-09-3036,2700.09%
BVF PARTNERS L P/ILSCHEDULE 13G/A2025-11-142025-09-30658,4211.6%
BIOTECHNOLOGY VALUE FUND L PSCHEDULE 13G/A2025-11-142025-09-30340,2780.8%
BIOTECHNOLOGY VALUE FUND II LPSCHEDULE 13G/A2025-11-142025-09-30268,7750.6%
BVF GP HOLDINGS LLCSCHEDULE 13G/A2025-11-142025-09-30609,0531.4%
BVF I GP LLCSCHEDULE 13G/A2025-11-142025-09-30340,2780.8%
BVF INC/ILSCHEDULE 13G/A2025-11-142025-09-30658,4211.6%
Lance G. LaingSCHEDULE 13G/A2025-11-132025-09-301,568,7663.6%
Brian F. SullivanSCHEDULE 13G/A2025-11-132025-09-304,013,2039.1%
Liza LandsmanSCHEDULE 13D/A2025-08-182025-08-1400%
Peter W. SonsiniSCHEDULE 13D/A2025-08-182025-08-1400%
Commodore Capital Master LPSCHEDULE 13G/A2025-02-142024-12-311,095,6502.9%
COMMODORE CAPITAL LPSCHEDULE 13G/A2025-02-142024-12-311,095,6502.9%
Soleus GP LLCSCHEDULE 13G/A2025-02-112024-12-313,797,8719.9%
BlackRock, Inc.SCHEDULE 13G2025-02-042024-12-312,179,0645.9%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.